ServiziMenu principaleHome
You are here: Home > Events > Past events > 2022 > Telemedicine in Cancer Care Continuum: implementation and integration
Download page in PDF

Telemedicine in Cancer Care Continuum: implementation and integration

06.05.2022  -  07.05.2022




Telemedicine promises to revolutionize care pathways for cancer patients as modern health systems design and conceptualize new ways to manage the entire Cancer Care Continuum, moving from hospital-centered models of care to a patient-centered, proximity-based approach to care. The fundamental concept is that information and data move, not patients. Prior to Covid-19, the world had experienced an uneven spread of digital health practices in its various applications, ranging from telemedicine to mobile health.

Prior to Covid-19, the world was experiencing an uneven spread of digital health practices, ranging from telemedicine to mobile health. The pandemic has undoubtedly produced an acceleration in the adoption of digital technologies, pushing regions and countries to consolidate projects already in the pipeline, or to move towards a first experience in the application of telemedicine to diagnosis, treatment and care, to limit waiting times and physical contact.

In this perspective, in collaboration with ASCO (American Society in Clinical Oncology), SPCC has launched the first phase of the Telemedicine in Cancer Care in 2021 project. The aim is to promote the topic of telemedicine from the state of the art and its tele-applications around the world, its potential, limitations, barriers and challenges, to the exploration of new frontiers.

The second phase of the project will focus on how to overcome both barriers and limitations, addressing new challenges through the sharing of best practices on telemedicine applications in the cancer care continuum. The goal is to create the best conditions to implement and integrate telemedicine applications to truly and effectively improve the cancer care pathway, first of all for patients and their relatives, but also for health systems, in terms of cost-effectiveness, efficiency and sustainability.

Conference Goals

  • To focus on the implementation and integration of telemedicine in the Cancer Care Continuum (e.g., critical success factors, technical barriers and organizational and legal issues)
  • To enhance cooperation between clinicians, HCPs and management (integrated and interconnected care team)
  • To share patient’s perspective and implications in telemedicine
  • To show the best practice experiences at regional/national level

Target Group

HCPs - Cancer Patients Organisations- Oncologists - Researchers - Medical Companies - Cancer Institutes – Academia - Healthcare Public Authorities - Regulatory and Policy Bodies - Technological institutes

Conference Format

The conference will be held online with the participation of world-renowned experts, some of them already involved in the 2021 “SPCC Telemedicine in Cancer Care Project".
It will be free of charge and can be accessed by registering on SPCC's OncoCorner e-learning platform. The material will remain available on-demand.

Conference Content

The event will consist of 2 consecutive days of live sessions with recorded and live contributions.

Faculty, programme and further information on the course will be available soon.

General Information


Sharing Progress in Cancer Care
Via Vincenzo Vela, 6
6500 Bellinzona – Switzerland

info@spcc.net - Tel: +41 91 820 09 58

CME Accreditation and Certificates

Application for CME accreditation has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 4 CME credits have been granted to this event.

Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.


The Conference will be held in collaboration with


Sharing Progress in Cancer Care wishes to express its appreciation to AstraZeneca, Eisai and Pfizer for having granted their support to the Conference.


06 May

14:30Welcome and Introduction
Matti Aapro, CH
14:40The new challenges of telemedicine in digital diagnosis and cancer prevention (after Covid pandemic)
Liron Pantanowitz, US
15:00Policy and reimbursement issues for an effective implementation of telemedicine in cancer care
Paul Cornes, UK
15:20Teleoncology for remote monitoring of treatments: pro and cons
Florian Scotté, FR
15:40Organizational and technological barriers and needs for telemonitoring and telerehabilitation
Ilan Misano, IL
16:05Q&A and Live Discussion
Matti Aapro, CH - Sanaa Al Sukhun, JO - Paul Cornes, UK - Ilan Misano, IL - Liron Pantanowitz, US - Florian Scotté, FR
16:30Closing Remarks
Matti Aapro, CH

07 May

14:30Welcome and Introduction
Andreas Charalambous, CY - Pietro Presti, IT
14:40The potential and the limits of telemedicine from Real World Data (RWD) to Real World Evidence (RWE)
Massimo Di Maio, IT
15:00A new patient-doctor "digital" relationship: ethical implications
Sanaa Al Sukhun, JO
15:20The digital stepped cancer care continuum: an emergent integrated model among telemedicine
Cristian Ochoa-Arnedo, ES
15:40The measurable impact of telemedicine on improving efficiency in the cancer care
Alex Filicevas, BE
16:05Q&A and Live Discussion
Sanaa Al Sukhun, JO - Andreas Charalambous, CY - Massimo Di Maio, IT - Alex Filicevas, BE - Cristian Ochoa-Arnedo, ES - Pietro Presti, IT
16:30Closing Remarks
Andreas Charalambous, CY - Pietro Presti, IT


Matti Aapro, Sharing Progress in Cancer Care and Clinique de Genolier, Bellinzona and Genolier, CH
Sanaa Al Sukhun, Al Hyatt Oncology Practice, Amman, JO
Andreas Charalambous, Cyprus University of Technology, University of Turku (Finland) and European Cancer Organisation, Limassol, CY
Paul Cornes, Comparative Outcomes Group, Bristol, UK
Massimo Di Maio, Univeristà degli Studi di Torino, Turin, IT
Alex Filicevas, Saint Gilles, BE
Ilan Misano, Technion Institute of Technology, Biomedical Engineering, Tel Aviv, IL
Cristian Ochoa-Arnedo, Catalan Institute of Oncology, ICOnnecta't digital health service, L'Hospitalet de Llobregat - Barcelona, ES
Liron Pantanowitz, University of Michigan, Department of Pathology, Ann Arbor, US
Pietro Presti, Sharing Progress in Cancer Care, Turin, IT
Florian Scotté, Institute Gustave Roussy, Villejuif, FR